Vicente Alfaro

5PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma.

Gregory M Cote, Sant P Chawla, George Demetri

|Oct 06, 2021
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.

Rebecca Kristeleit, Victor Moreno, Valentina Boni

|Mar 19, 2021
Lurbinectedin in the treatment of relapsed small cell lung cancer.

Javier Baena, Andrea Modrego, Ali Zeaiter

|Oct 27, 2020
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysis.

Salvador Fudio, Josep Tabernero, Vivek Subbiah

Pageof 1